Summary

tulipforce7 Newbie

  • Multicenter, stage II study of response-adapted lenalidomide-based remedy for transplant-ineligible people with freshly diagnosed several myeloma with out high-risk characteristics.
Offline Offline
Posts:
0 (0 per day)
Age:
N/A
Date Registered:
May 09, 2024, 11:31:37 AM
Local Time:
June 01, 2024, 02:28:07 PM
Last Active:
May 09, 2024, 03:33:46 PM
Signature:
Additional research along with greater collection are required to measure the preoperative and postoperative solution calprotectin values ​&#820